Countdown to the Event

See you in 72 days 22 hours 3 minutes
  • 72
    Days
  • 22
    Hours
  • 3
    Minutes
  • 16
    Seconds

ISAAI Members: Select the level that best describes you and use code ISAAI1025 to claim your free registration.

Registrants will be checked for membership status.

ISAAI Membership

ISAAI Membership Interested in Membership and attending all ISAAI conferences for free? If you are ready to become a member of ISAAI, please click the button below learn more and submitt an application.

Annual Membership Dues Annual membership's are due January 1, 2026, so please click the button below to renew or start a ISAAI membership for 2026.

Course Description

The purpose of this activity is to provide allergists and immunologists with up-to-date information on primary and secondary immunodeficiency disease states and advances on ordering and interpreting relevant genetic testing. The meeting will conclude with presentations from local allergy fellows-in-training.

Learning Objectives

  1. Identify at least three key environmental exposures (e.g., diet, pollutants, microbial/animal exposures) that influence the gut, and respiratory microbiome and describe their role in allergic disease development.
  2. Explain at least two mechanisms by which microbiome alterations across barrier sites (gut, skin, airway) contribute to immune dysregulation and allergic inflammation, and apply this knowledge to clinical or prevention-focused scenario.
  3. Describe the respiratory and allergy related health effects of vaping, e-cigs, and cannabis use in patients with asthma and allergic disease. 
  4. Apply a patient centered, nonjudgmental counseling approach to screen for and discuss vaping and cannabis use with patients.
  5. Describe the impact of atopic conditions — including asthma, allergic rhinitis, and atopic dermatitis — on maternal and fetal outcomes, and apply evidence-based management strategies to optimize control during pregnancy.
  6. Describe the pathophysiology and clinical presentation of pediatric eosinophilic gastrointestinal disorders (EGIDs), including key differences among EoE and non-EoE EGIDs.
  7. Apply current diagnostic criteria and management strategies to pediatric EGID cases, including selection of pharmacologic, dietary, and endoscopic interventions.

Target Audience

Allergy/Immunology Physicians, Youth/Adult Primary Care Providers, Nurses, Allied Health Professionals, Clinical Staff, Fellows-in-Training, Residents, and anyone with an academic interest in Allergy/Immunology.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the Illinois Society of Allergy, Asthma & Immunology. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 5.50 Contact Hours.

Sponsor or Exhibit

Please contact Regan Cook at Regan@Meetingachievements.com if interested in Sponsorship/Exhibitor opportunities. We will register you upon receipt of the required paperwork.